species reactivity
human
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type urine
sample type plasma
sample type serum
sample type cell culture supernatant(s)
assay range
inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 6 pg/mL
standard curve range: 7.373-1800 pg/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... AFP(174)
General description
AFP ELISA试剂盒用于定量测量细胞培养上清、血浆和血清中的甲胎蛋白。
Application
Biochem/physiol Actions
α-胎蛋白(AFP)可促进成胎儿和增殖中的人肝脏细胞中的脂肪酸调节。已在急性肝损伤中观察到该基因的过表达,表明活跃的肝再生。AFP与可能导致肝硬化和肝细胞癌的脂肪肝疾病(FLD)相关。它可作为HCC(肝细胞癌)的一种肿瘤标志物。
Other Notes
本产品提供样本分析证书。
请在批号对应的文本框中输入单词 sample 。
请在批号对应的文本框中输入单词 sample 。
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
flash_point_f
Not applicable
flash_point_c
Not applicable
存储类别
10 - Combustible liquids
法规信息
常规特殊物品
低风险生物材料
此项目有
Novel photoelectrochemical immunosensor for disease-related protein assisted by hemin/G-quadruplex-based DNAzyme on gold nanoparticles to enhance cathodic photocurrent on p-CuBi2O4 semiconductor.
Lv S, et al.
Biosensors And Bioelectronics, 96, 317-323 (2017)
Abdel Hady A Abdel Wahab et al.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 22(7), 621-628 (2016-10-30)
The incidence rate of hepatocellular carcinoma (HCC) is higher in developing countries, and most cases are associated with chronic hepatitis C virus (HCV) infection. To evaluate the circulating proteins as liver biomarkers for the identification of HCC associated with HCV
Garima Singhal et al.
Molecular metabolism, 13, 56-66 (2018-05-14)
Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseases which can progress to non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Fibroblast growth factor 21 (FGF21) plays an important role in liver metabolism and is also
Kenya Kamimura et al.
Cancers, 12(2) (2020-02-23)
Hepatocellular carcinoma (HCC) is a major global malignancy, responsible for >90% of primary liver cancers. Currently available therapeutic options have poor performances due to the highly heterogeneous nature of the tumor cells; recurrence is highly probable, and some patients develop
Gianluigi Giannelli et al.
PloS one, 15(3), e0222259-e0222259 (2020-03-27)
Transforming growth factor beta (TGF-β) signalling is involved in the development of hepatocellular carcinoma (HCC). We followed changes in biomarkers during treatment of patients with HCC with the TGF-βRI/ALK5 inhibitor galunisertib. This phase 2 study (NCT01246986) enrolled second-line patients with
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| RAB0602-1KT | 04061835164059 |
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持